Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
Apr 29, 2025 • 2min
BTK Inhibitors in Multiple Sclerosis Treatment - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how to address questions related to BTK Inhibitors with patients. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
Apr 28, 2025 • 4min
BTK Inhibitors in Multiple Sclerosis Treatment - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss the clinical trial data available in both the relapsing and progressive cohorts. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
Apr 24, 2025 • 4min
BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
Apr 23, 2025 • 3min
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Dr. Justin Abbatemarco provides an update on autologous hematopoietic stem cell transplantation in multiple sclerosis. Show reference: https://www.nature.com/articles/s41582-024-01050-x
Apr 22, 2025 • 3min
Women History Minute - Mary A. B. Brazier
In this women's history minute, Dr. Alison Christy discusses the life and legacy of Mary A. B. Brazier.
Apr 21, 2025 • 2min
The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss the diverse strategies that residency programs implement to ensure residents can continue their education in a protected and supportive environment. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205
Apr 18, 2025 • 2min
The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss how neurology residency programs are incorporating didactic teaching methods to enhance learning outside the clinical environment. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205
Apr 17, 2025 • 2min
Characterizing Prodrome in Migraine
Dr. Jessica Ailani and Dr. Richard B. Lipton discuss the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200359
Apr 16, 2025 • 2min
Estrogen Exposure from Modern Hormonal Contraceptives and Vascular Risk in Women with Migraine: A Nationwide Electronic Health Record Database Study
Discover the intriguing relationship between hormonal contraceptives and vascular risks in women who suffer from migraines. A recent study shows no major differences in vascular health between users and non-users of estrogen-containing contraceptives. However, it sheds light on an increased stroke risk for non-user women experiencing migraine with aura. Tune in to unpack these findings and their implications for women's health!
Apr 15, 2025 • 3min
The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 4
In the final episode of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss the abstract she presented at the AAN Annual Meeting and details on the upcoming gene therapy trial. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000208987
